GlassScriptPhysician profile
Michael David Patterson
NPI 1851654867
$138,326.76
in general payments reported to CMS, 2019-2025
36 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $8,000 · 2021: $15K · 2022: $7,579 · 2023: $22K · 2024: $32K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $69K · Food and Beverage: $5,266 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $69,184.38 |
| Food and Beverage | $5,266.05 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $43,754.03 | 2022-2025 | Envista Mx60 Iol, Envista Envy Iol, Stellaris Elite |
| Johnson & Johnson Surgical Vision, INC. | $39,118.74 | 2019-2025 | Compact Intuitiv, Ifs Advanced Femtosec Laser, Intralase Fs Femtosec Laser |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16,905.50 | 2019-2021 | |
| Ivantis, INC | $10,323.39 | 2019-2021 | |
| Sight Sciences, INC. | $8,318.35 | 2019-2021 | |
| Glaukos Corporation | $5,915.13 | 2019-2025 | Travoprost Intraocular Implant - Idose, Idosetr, Idose |
| Carl Zeiss Meditec, INC. | $4,145.99 | 2019-2021 | |
| New World Medical,INC. | $3,288.98 | 2020-2025 | Kahook Dual Blade, Streamline, Clearpath |
| Abbvie INC. | $1,535.35 | 2022-2025 | |
| Allergan, INC. | $1,387.61 | 2019-2022 | |
| Alcon Vision LLC | $870.46 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Harrow Eye, LLC | $547.57 | 2023-2025 | Iheezo, Vevye |
| Carl Zeiss Meditec USA, INC. | $476.63 | 2021-2022 | |
| Genentech USA, INC. | $396.05 | 2023-2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $289.40 | 2023-2025 | Syfovre |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $206.75 | 2019-2025 | Eylea Hd, Eylea |
| Omeros Corporation | $192.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $84.04 | 2019-2022 | |
| Staar Surgical Company | $82.09 | 2019 | |
| Mallinckrodt Hospital Products INC. | $54.77 | 2022 | |
| Dompe US, INC. | $50.70 | 2019-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $50.56 | 2022-2025 | Cequa |
| Rayner Intraocular Lenses Limited | $44.96 | 2022-2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Biotissue Holdings INC. | $44.81 | 2019-2024 | |
| Alimera Sciences, INC. | $37.74 | 2022-2024 | Yutiq, Iluvien |
| Eyevance Pharmaceuticals LLC | $34.33 | 2020 | |
| Iridex Corporation | $32.52 | 2020-2022 | |
| Astellas Pharma US INC | $25.25 | 2025 | Izervay |
| Biogen, INC. | $17.70 | 2023 | |
| Horizon Therapeutics Plc | $15.60 | 2021 | |
| Ani Pharmaceuticals, INC. | $15.49 | 2024 | Purified Cortrophin Gel |
| Oyster Point Pharma, INC. | $15.33 | 2022 | |
| Lombart Brothers, INC. | $12.91 | 2019 | |
| Rxsight INC | $12.01 | 2022 | |
| Ocular Therapeutix, INC. | $11.97 | 2022 | |
| Eyepoint US, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.